FI114474B - Menetelmä terapeuttisesti käyttökelpoisten emäksisten kvaternääristen amidien valmistamiseksi - Google Patents

Menetelmä terapeuttisesti käyttökelpoisten emäksisten kvaternääristen amidien valmistamiseksi Download PDF

Info

Publication number
FI114474B
FI114474B FI934273A FI934273A FI114474B FI 114474 B FI114474 B FI 114474B FI 934273 A FI934273 A FI 934273A FI 934273 A FI934273 A FI 934273A FI 114474 B FI114474 B FI 114474B
Authority
FI
Finland
Prior art keywords
group
phenyl
azabicyclo
compound
vacuo
Prior art date
Application number
FI934273A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI934273A (fi
FI934273A0 (fi
Inventor
Xavier Emonds-Alt
Patrick Gueule
Vincenzo Proietto
Broeck Didier Van
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of FI934273A0 publication Critical patent/FI934273A0/fi
Publication of FI934273A publication Critical patent/FI934273A/fi
Application granted granted Critical
Publication of FI114474B publication Critical patent/FI114474B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
  • Indole Compounds (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FI934273A 1992-09-30 1993-09-29 Menetelmä terapeuttisesti käyttökelpoisten emäksisten kvaternääristen amidien valmistamiseksi FI114474B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9212083 1992-09-30
FR9212083A FR2696178B1 (fr) 1992-09-30 1992-09-30 Amides basiques quaternaires, procédé pour leur préparation et compositions pharmaceutiques en contenant.

Publications (3)

Publication Number Publication Date
FI934273A0 FI934273A0 (fi) 1993-09-29
FI934273A FI934273A (fi) 1994-03-31
FI114474B true FI114474B (fi) 2004-10-29

Family

ID=9434374

Family Applications (1)

Application Number Title Priority Date Filing Date
FI934273A FI114474B (fi) 1992-09-30 1993-09-29 Menetelmä terapeuttisesti käyttökelpoisten emäksisten kvaternääristen amidien valmistamiseksi

Country Status (27)

Country Link
EP (1) EP0591040B1 (xx)
JP (2) JP2857041B2 (xx)
KR (1) KR100279084B1 (xx)
CN (1) CN1036652C (xx)
AT (1) ATE176469T1 (xx)
AU (1) AU674875B2 (xx)
BR (1) BR9303982A (xx)
CA (1) CA2107432C (xx)
CZ (1) CZ287272B6 (xx)
DE (1) DE69323375T2 (xx)
DK (1) DK0591040T3 (xx)
ES (1) ES2130238T3 (xx)
FI (1) FI114474B (xx)
FR (1) FR2696178B1 (xx)
GR (1) GR3030000T3 (xx)
HU (2) HU215848B (xx)
IL (1) IL107158A0 (xx)
MX (1) MX9306024A (xx)
MY (1) MY108881A (xx)
NO (1) NO304888B1 (xx)
NZ (1) NZ248821A (xx)
OA (1) OA09869A (xx)
RU (1) RU2120436C1 (xx)
SG (1) SG47807A1 (xx)
SI (1) SI9300513B (xx)
TW (1) TW242625B (xx)
ZA (1) ZA937276B (xx)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5583134A (en) * 1992-09-30 1996-12-10 Sanofi 1-azoniabicyclo[2.2.2] octanes and pharmaceutical compositions in which they are present
FR2717804B1 (fr) * 1994-03-25 1996-06-21 Sanofi Sa Sels de composés hétéroaromatiques azotés substitués, procédé pour leur préparation et compositions pharmaceutiques en contenant.
FR2717802B1 (fr) * 1994-03-25 1996-06-21 Sanofi Sa Nouveaux composés aromatiques, procédé pour leur préparation et compositions pharmaceutiques en contenant.
IL113472A0 (en) 1994-04-29 1995-07-31 Lilly Co Eli Non-peptidyl tachykinin receptor antogonists
CN1067067C (zh) 1994-07-12 2001-06-13 伊莱利利公司 杂环速激肽受体拮抗物
FR2725900B1 (fr) * 1994-10-21 1997-07-18 Sanofi Sa Utilisation d'antagonistes des recepteurs nk1 pour la preparation de medicaments a action cardioregulatrice
US6008223A (en) * 1994-10-27 1999-12-28 Zeneca Limited Therapeutic compounds
GB9421709D0 (en) * 1994-10-27 1994-12-14 Zeneca Ltd Therapeutic compounds
CA2162786A1 (en) * 1994-11-22 1996-05-23 Philip Arthur Hipskind Heterocyclic tachykinin receptor antagonists
FR2729951B1 (fr) * 1995-01-30 1997-04-18 Sanofi Sa Nouveaux composes heterocycliques, procede pour leur preparation et compositions pharmaceutiques en contenant
FR2751654B1 (fr) * 1996-07-26 1998-10-23 Sanofi Sa Composes heterocycliques substitues, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2729954B1 (fr) * 1995-01-30 1997-08-01 Sanofi Sa Composes heterocycliques substitues, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2729952B1 (fr) * 1995-01-30 1997-04-18 Sanofi Sa Composes heterocycliques substitues, procede pour leur preparation et compositions pharmaceutiques les contenant
US5654316A (en) * 1995-06-06 1997-08-05 Schering Corporation Piperidine derivatives as neurokinin antagonists
DE69626123T2 (de) * 1995-06-06 2003-10-09 Schering Corp Substituierte benzokondensierte heterocyclen als neurokinin antagonisten
FR2745811B1 (fr) * 1996-03-07 1998-05-22 Sanofi Sa Glutarimide disubstitue procede pour sa preparation, et son utilisation
WO1997044035A1 (en) * 1996-05-24 1997-11-27 Eli Lilly And Company Methods of treating hypertension
US5691362A (en) * 1996-06-05 1997-11-25 Schering-Plough Corporation Substituted benzene-fused hetero- and carbocyclics as nuerokinin antagonists
GB9617730D0 (en) * 1996-08-23 1996-10-02 Pfizer Ltd Quarternary ammonium compounds
FR2759584B1 (fr) * 1997-02-17 1999-06-11 Sanofi Sa Composition pharmaceutique pour l'administration orale de composes heterocycliques sous forme ammonium quaternaire
FR2759585B1 (fr) * 1997-02-17 1999-06-11 Sanofi Sa Formulations pharmaceutiques presentees sous forme seche pour l'administration orale d'un compose ammonium quaternaire cyclique
CA2287487A1 (en) * 1997-04-24 1998-10-29 Merck Sharp & Dohme Limited Use of nk-1 receptor antagonists for treating eating disorders
GB9712882D0 (en) * 1997-06-18 1997-08-20 Pfizer Ltd Quaternary ammonium compounds
CA2298777A1 (en) * 1997-08-04 1999-02-18 Merck Sharp & Dohme Limited Use of nk-1 receptor antagonists for treating mania
WO1999007375A1 (en) * 1997-08-04 1999-02-18 Merck Sharp & Dohme Limited Use of nk-1 receptor antagonists for treating aggressive behaviour disorders
GB9716463D0 (en) * 1997-08-04 1997-10-08 Merck Sharp & Dohme Therapeutic agents
GB9716457D0 (en) * 1997-08-04 1997-10-08 Merck Sharp & Dohme Therapeutic agents
GB9816897D0 (en) * 1998-08-04 1998-09-30 Merck Sharp & Dohme Therapeutic use
GB9927125D0 (en) 1999-11-16 2000-01-12 Univ Reading The Placental human neurokinin B precursor
EP1754701A4 (en) 2004-02-25 2007-10-03 Sankyo Co sulphonyloxy derivatives
WO2006102308A2 (en) 2005-03-22 2006-09-28 Azevan Pharmaceuticals, Inc. Beta-lactamyl vasopressin v1b antagonists
SI1910346T1 (sl) 2005-07-19 2019-08-30 Azevan Pharmaceuticals, Inc. Antagonist beta-laktamil fenilalalina, cisteina in serin vasopresina
CA2676357A1 (en) 2007-01-24 2008-07-31 Glaxo Group Limited Pharmaceutical compositions comprising 3, 5-diamin0-6- (2, 3-dichl0phenyl) -l, 2, 4-triazine or r (-) -2, 4-diamino-5- (2, 3-dichlorophenyl) -6-fluoromethyl pyrimidine and an nk1
UA105182C2 (ru) 2008-07-03 2014-04-25 Ньюрексон, Інк. Бензоксазины, бензотиазины и родственные соединения, которые имеют ингибирующую nos активность
CN103269584B (zh) 2010-07-01 2017-05-03 阿泽凡药物公司 用于治疗创伤后应激障碍的方法
KR20160130853A (ko) 2014-03-28 2016-11-14 아제반 파마슈티칼스, 인코퍼레이티드 신경변성 질환을 치료하기 조성물 및 방법
CA3047023C (en) * 2016-12-14 2022-05-31 Beijing Showby Pharmaceutical Co., Ltd. Class of bifunctional compounds with quaternary ammonium salt structure
AU2018333051B2 (en) 2017-09-15 2024-03-21 Azevan Pharmaceuticals, Inc. Compositions and methods for treating brain injury

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE903957A1 (en) * 1989-11-06 1991-05-08 Sanofi Sa Aromatic amine compounds, their method of preparation and¹pharmaceutical compositions in which they are present
FR2666185B1 (fr) * 1990-08-21 1992-12-04 Sgs Thomson Microelectronics Convertisseur analogique/numerique a interpolation.
IL99320A (en) * 1990-09-05 1995-07-31 Sanofi Sa Arylalkylamines, their preparation and pharmaceutical preparations containing them

Also Published As

Publication number Publication date
NZ248821A (en) 1995-10-26
JP2857041B2 (ja) 1999-02-10
CZ287272B6 (en) 2000-10-11
GR3030000T3 (en) 1999-07-30
MY108881A (en) 1996-11-30
NO304888B1 (no) 1999-03-01
EP0591040B1 (fr) 1999-02-03
TW242625B (xx) 1995-03-11
HU215848B (hu) 1999-04-28
CN1088582A (zh) 1994-06-29
EP0591040A1 (fr) 1994-04-06
KR100279084B1 (ko) 2001-01-15
FR2696178B1 (fr) 1994-12-30
ATE176469T1 (de) 1999-02-15
CA2107432A1 (en) 1994-03-31
OA09869A (fr) 1994-08-15
SI9300513B (sl) 2002-02-28
NO933481D0 (no) 1993-09-29
MX9306024A (es) 1994-03-31
JP3243212B2 (ja) 2002-01-07
RU2120436C1 (ru) 1998-10-20
BR9303982A (pt) 1994-10-25
KR940007026A (ko) 1994-04-26
NO933481L (no) 1994-04-05
SI9300513A (en) 1994-06-30
JPH06211850A (ja) 1994-08-02
SG47807A1 (en) 1998-04-17
JPH10175976A (ja) 1998-06-30
DE69323375D1 (de) 1999-03-18
AU674875B2 (en) 1997-01-16
HUT65759A (en) 1994-07-28
HU211889A9 (en) 1995-12-28
ZA937276B (en) 1994-04-25
DE69323375T2 (de) 1999-06-24
CN1036652C (zh) 1997-12-10
FI934273A (fi) 1994-03-31
DK0591040T3 (da) 1999-09-20
ES2130238T3 (es) 1999-07-01
AU4870893A (en) 1994-04-14
CA2107432C (en) 2000-04-04
CZ203593A3 (en) 1994-04-13
FR2696178A1 (fr) 1994-04-01
FI934273A0 (fi) 1993-09-29
HU9302770D0 (en) 1993-12-28
IL107158A0 (en) 1993-12-28

Similar Documents

Publication Publication Date Title
FI114474B (fi) Menetelmä terapeuttisesti käyttökelpoisten emäksisten kvaternääristen amidien valmistamiseksi
KR100258373B1 (ko) 다환아민화합물및그의거울상이성질체,그의제조방법및이를함유하는제약학적조성물
KR101125305B1 (ko) Ｎ-헤테로시클릴메틸벤즈아미드의 유도체, 그의 제조 방법및 치료에 있어서 그의 적용
AU741839B2 (en) N-substituted azaheterocyclic compounds
PT96405B (pt) Processo para a preparacao de derivados da 3-aminopiperidina e de heterociclos afins contendo azoto
IE83893B1 (en) Polycyclic amine compounds and their enantiomers, their method of preparation and pharmaceutical compositions in which they are present
JPH08245622A (ja) 新規複素環化合物、それらの調製方法およびそれらを含有する医薬組成物
ES2203327B1 (es) Nuevos carbamatos de quinuclidina y composiciones farmaceuticas que los contienen.
JP2007508358A (ja) Ｎ−［フェニル（ピペリジン−２−イル）メチル］ベンズアミド誘導体、この調製方法およびこの治療法における使用
JP2007508362A (ja) Ｎ−［フェニル（ピロリジン−２−イル）メチル］ベンズアミドおよびｎ−［（アゼパン−２−イル）フェニルメチル］ベンズアミド誘導体、この調製方法および治療法における使用
DE69630717T2 (de) 1-acyl-3-phenyl-3-(3-piperidinopropyl)piperidinderivate als für den menschlichen nk3-rezeptor selektive antagonisten
KR20040103973A (ko) Ｎ-[페닐(피페리딘-2-일)메틸]벤즈아미드의 유도체, 그의제조 방법 및 치료법에서의 그의 용도
US5583134A (en) 1-azoniabicyclo[2.2.2] octanes and pharmaceutical compositions in which they are present
JPH05213751A (ja) 一連のアレコロンおよびイソアレコロンのニコチン様活性
US5679693A (en) 1-azoniabicyclo 2.2.1!heptanes, method of preparing them and pharmaceutical compositions in which they are present
WO2004030668A1 (en) 4-aminopiperidine derivatives, processes for their preparation and their use as medicaments
WO2000049017A1 (en) 1-((indoly azacycloalkyl) alkyl)-2,1, 3-benzothiadiazole 2,2-dioxides exhibiting 5-ht2a receptor activity
KR20050024450A (ko) 신규한 퀴누클리딘 아미드 유도체

Legal Events

Date Code Title Description
HC Name/ company changed in application

Owner name: SANOFI

FG Patent granted

Ref document number: 114474

Country of ref document: FI

PC Transfer of assignment of patent

Owner name: SANOFI-AVENTIS